Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma
Abstract Background Interleukin‐33 (IL‐33) exacerbates asthma probably through type 2 innate lymphoid cells (ILC2s). Nevertheless, the association between eosinophilic asthma (EA) and ILC2s remains obscure, and the mechanisms by which IL‐33 affects ILC2s are yet to be clarified. Methods ILC2s were e...
Main Authors: | Fengfei Sun, Wei Zou, Honglei Shi, Zehu Chen, Donghai Ma, Minmin Lin, Kongqiu Wang, Yiying Huang, Xiaobin Zheng, Cuiyan Tan, Meizhu Chen, Changli Tu, Zhenguo Wang, Jian Wu, Weiming Wu, Jing Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-06-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | https://doi.org/10.1002/clt2.12265 |
Similar Items
-
Rapamycin Dampens Inflammatory Properties of Bone Marrow ILC2s in IL-33-Induced Eosinophilic Airway Inflammation
by: Emma Boberg, et al.
Published: (2022-06-01) -
Clinical Significance of Interleukin 33 (IL-33) in Patients with Eosinophilic Pneumonia
by: Naoko Mato, et al.
Published: (2013-01-01) -
Type 2 innate lymphoid cells are protective against hepatic ischaemia/reperfusion injury
by: Qi Cao, et al.
Published: (2023-10-01) -
The Neutralization of the Eosinophil Peroxidase Antibody Accelerates Eosinophilic Mucin Decomposition
by: Yoshiki Kobayashi, et al.
Published: (2023-11-01) -
Eosinophil granule proteins and bronchial asthma
by: Gerald J Gleich
Published: (1996-01-01)